Sfoglia per Titolo
C metric: the equatorial plane and Fermi coordinates
2005-01-01 Bini, D.; Cherubini, C.; Filippi, S; Geralico, A.
C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age at onset of Type 1 diabetes
2004-01-01 Pozzilli, P; Pitocco, D; Visalli, N; Spera, S; Corbi, S; Suraci, C; Crino, A; Patera, P; Matteoli, Mc; Costanza, F; Fioriti, E; Ghirlanda, G; Cappa, M; Grp, I
C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes
2004-01-01 Pozzilli, P; Visalli, N; Picardi, A; Manfrini, S; Crino, A; Suraci, C; Pitocco, D; Ghirlanda, G; Patera, P
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004)
2004-01-01 Palmer, Jp; Fleming, Ga; Greenbaum, Cj; Herold, Kc; Jansa, Ld; Kolb, H; Lachin, Jm; Polonsky, Ks; Pozzilli, P; Skyler, Js; Steffes, Mw
C-peptide response and HLA genotype in subjects with recent onset type 1 diabetes following immunotherapy with DiaPep277
2009-01-01 Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P
C-Peptide response and HLA genotypes in subjects with recent onset type 1 diabetes following immunotherapy with diapep277
2009-01-01 Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P
C-Peptide Response and HLA Genotypes in Subjects with Recent Onset Type 1 Diabetes Following Immunotherapy with Diapep277
2009-01-01 Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P
C-peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277 An Exploratory Study
2011-01-01 Buzzetti, R; Cernea, S; Petrone, A; Capizzi, M; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P
C-peptide two years after diagnosis of Type 1 diabetes: the effect of nicotinamide and intensive insulin therapy
2002-01-01 Visalli, N; Crino, A; Schiaffini, R; Matteoli, M; Patera, P; Pitocco, D; Ghirlanda, G; Manfrini, S; Suraci, C; Pozzilli, P
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels
2023-01-01 De Cicco Nardone, Carlo; De Luca, Cristiana; Plotti, Francesco; Fabris, Silvia; Rossini, Gianmarco; Montera, Roberto; Luvero, Daniela; Angioli, Roberto; Terranova, Corrado
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD)
2011-01-01 Corsonello, A; Pedone, C; Battaglia, S; Paglino, G; Bellia, V; Antonelli Incalzi, R
Ca 125 and fdg-pet in determining pathological complete response in ovarian cancer patients.
2007-01-01 Perniola, G; Angioli, R; Basile, S; Palaia, I; Plotti, F; Graziano, M; Servodio, C; Pecorini, F; Montera, R; Muzii, L; Benedetti Panici, P.
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
2021-01-01 Coppola, A; La Vaccara, V; Fiore, M; Farolfi, T; Ramella, S; Angeletti, S; Coppola, R; Caputo, D
CA2 Gene Polymorphisms Are Associated with Specific Eye Colour and Skin Phenotype in Type 1 Diabetes
2010-01-01 Spoletini, M; Maggi, D; Zampetti, S; Astorri, E; Buzzetti, R; Pozzilli, P; Imdiab, G
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment
2018-01-01 Fioramonti, M; Fausti, V; Pantano, F; Iuliani, M; Ribelli, G; Lotti, F; Pignochino, Y; Grignani, G; Santini, D; Tonini, G; Vincenzi, B
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis
2020-01-01 Iacovelli, R; Ciccarese, C; Facchini, G; Milella, M; Urbano, F; Basso, U; De Giorgi, U; Sabbatini, R; Santini, D; Berardi, R; Santoni, M; Bracarda, S; Massari, F; Masini, C; De Tursi, M; Ricotta, R; Buti, S; Zustovich, F; Sepe, P; Rossetti, S; Maruzzo, M; Cortesi, E; Tortora, G; Procopio, G
Cabozantinib and apixaban: an hitherto unreported interaction
2019-01-01 Santini, D; Citarella, F; Vincenzi, B; Russano, M; Tonini, G; Stellato, M
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
2022-01-01 Mennitto, A.; Zattarin, E.; Di Maio, M.; Bimbatti, D.; De Giorgi, U.; Buti, S.; Santini, D.; Casadei, C.; Soraru, M.; Messina, C.; Mucciarini, C.; Di Lorenzo, G.; Roviello, G.; Buttigliero, C.; Stellato, M.; Sepe, P.; Claps, M.; Guadalupi, V.; Ottini, A.; Pignata, S.; De Braud, F. G.; Verzoni, E.; Procopio, G.
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions
2017-01-01 Fioramonti, M; Santini, D; Iuliani, M; Ribelli, G; Manca, P; Papapietro, N; Spiezia, F; Vincenzi, B; Denaro, V; Russo, A; Tonini, G; Pantano, F
A CAD system for IIF tests
2009-01-01 Soda, P; Iannello, G
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
C metric: the equatorial plane and Fermi coordinates | 1-gen-2005 | Bini, D.; Cherubini, C.; Filippi, S; Geralico, A. | |
C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age at onset of Type 1 diabetes | 1-gen-2004 | Pozzilli, P; Pitocco, D; Visalli, N; Spera, S; Corbi, S; Suraci, C; Crino, A; Patera, P; Matteoli, Mc; Costanza, F; Fioriti, E; Ghirlanda, G; Cappa, M; Grp, I | |
C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes | 1-gen-2004 | Pozzilli, P; Visalli, N; Picardi, A; Manfrini, S; Crino, A; Suraci, C; Pitocco, D; Ghirlanda, G; Patera, P | |
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004) | 1-gen-2004 | Palmer, Jp; Fleming, Ga; Greenbaum, Cj; Herold, Kc; Jansa, Ld; Kolb, H; Lachin, Jm; Polonsky, Ks; Pozzilli, P; Skyler, Js; Steffes, Mw | |
C-peptide response and HLA genotype in subjects with recent onset type 1 diabetes following immunotherapy with DiaPep277 | 1-gen-2009 | Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P | |
C-Peptide response and HLA genotypes in subjects with recent onset type 1 diabetes following immunotherapy with diapep277 | 1-gen-2009 | Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P | |
C-Peptide Response and HLA Genotypes in Subjects with Recent Onset Type 1 Diabetes Following Immunotherapy with Diapep277 | 1-gen-2009 | Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P | |
C-peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277 An Exploratory Study | 1-gen-2011 | Buzzetti, R; Cernea, S; Petrone, A; Capizzi, M; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P | |
C-peptide two years after diagnosis of Type 1 diabetes: the effect of nicotinamide and intensive insulin therapy | 1-gen-2002 | Visalli, N; Crino, A; Schiaffini, R; Matteoli, M; Patera, P; Pitocco, D; Ghirlanda, G; Manfrini, S; Suraci, C; Pozzilli, P | |
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels | 1-gen-2023 | De Cicco Nardone, Carlo; De Luca, Cristiana; Plotti, Francesco; Fabris, Silvia; Rossini, Gianmarco; Montera, Roberto; Luvero, Daniela; Angioli, Roberto; Terranova, Corrado | |
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD) | 1-gen-2011 | Corsonello, A; Pedone, C; Battaglia, S; Paglino, G; Bellia, V; Antonelli Incalzi, R | |
Ca 125 and fdg-pet in determining pathological complete response in ovarian cancer patients. | 1-gen-2007 | Perniola, G; Angioli, R; Basile, S; Palaia, I; Plotti, F; Graziano, M; Servodio, C; Pecorini, F; Montera, R; Muzii, L; Benedetti Panici, P. | |
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis | 1-gen-2021 | Coppola, A; La Vaccara, V; Fiore, M; Farolfi, T; Ramella, S; Angeletti, S; Coppola, R; Caputo, D | |
CA2 Gene Polymorphisms Are Associated with Specific Eye Colour and Skin Phenotype in Type 1 Diabetes | 1-gen-2010 | Spoletini, M; Maggi, D; Zampetti, S; Astorri, E; Buzzetti, R; Pozzilli, P; Imdiab, G | |
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment | 1-gen-2018 | Fioramonti, M; Fausti, V; Pantano, F; Iuliani, M; Ribelli, G; Lotti, F; Pignochino, Y; Grignani, G; Santini, D; Tonini, G; Vincenzi, B | |
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis | 1-gen-2020 | Iacovelli, R; Ciccarese, C; Facchini, G; Milella, M; Urbano, F; Basso, U; De Giorgi, U; Sabbatini, R; Santini, D; Berardi, R; Santoni, M; Bracarda, S; Massari, F; Masini, C; De Tursi, M; Ricotta, R; Buti, S; Zustovich, F; Sepe, P; Rossetti, S; Maruzzo, M; Cortesi, E; Tortora, G; Procopio, G | |
Cabozantinib and apixaban: an hitherto unreported interaction | 1-gen-2019 | Santini, D; Citarella, F; Vincenzi, B; Russano, M; Tonini, G; Stellato, M | |
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) | 1-gen-2022 | Mennitto, A.; Zattarin, E.; Di Maio, M.; Bimbatti, D.; De Giorgi, U.; Buti, S.; Santini, D.; Casadei, C.; Soraru, M.; Messina, C.; Mucciarini, C.; Di Lorenzo, G.; Roviello, G.; Buttigliero, C.; Stellato, M.; Sepe, P.; Claps, M.; Guadalupi, V.; Ottini, A.; Pignata, S.; De Braud, F. G.; Verzoni, E.; Procopio, G. | |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions | 1-gen-2017 | Fioramonti, M; Santini, D; Iuliani, M; Ribelli, G; Manca, P; Papapietro, N; Spiezia, F; Vincenzi, B; Denaro, V; Russo, A; Tonini, G; Pantano, F | |
A CAD system for IIF tests | 1-gen-2009 | Soda, P; Iannello, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile